1. AB0428 Preferences in the use of biologic drugs and adverse events in patients with rheumatic disease from a national biologics registry in mÉxico. (12th June 2018) Authors: Xibillé, D.; Carrillo, S.; Sicsik, S.; Irazoque, F.; Ramos, A.; Durán, S.; Saavedra, M.; Barile, L.; Olvera, G. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study. (23rd January 2014) Authors: Gottenberg, J.-E.; Mpofu, C.; Bensen, W.; Rubbert-Roth, A.; Irazoque, F.; Martínez Taboada, V.; Chung, C.; Hinsch-Gylvin, L.; Ferri, C.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗